← Leaderboards
Dost Ongur
Mclean Hospital
$17,996,987
Attributed
$21,927,829
Total exposure
20
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.9M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,941,262 · 21
By mechanism
P50$21,447,976 · 8
R01$10,921,511 · 7
R21$1,112,751 · 3
K24$749,468 · 1
K23$684,556 · 1
R13$25,000 · 1
Top collaborators
- John Hsu15 shared
- Miguel Hernan11 shared
- Fei Du7 shared
- Xi Chen3 shared
Most similar at Mclean Hospital
Same institution · by research overlap
- Fei Du$6,859,154
- Abdullah Cagri Yuksel$852,450
Others in their field
Top investigators on “Schizophrenia”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,668,216
- Raquel E Gur · University Of Pennsylvania$60,189,770
- Mark J Daly · Broad Institute, Inc.$48,989,393
- John M Kane · Long Island Jewish Medical Center$45,235,871
- Carrie E Bearden · University Of California Los Angeles$42,025,230
- Scott W Woods · Yale University$41,221,536
Research focus
SchizophreniaDesignNational Institute Of Mental HealthFirst Episode PsychosisResearch PersonnelCollaborationsReportingBaseMental HealthFutureFundingLeadClinicProgramsMassachusettsPharmaceutical PreparationsCaringResourcesFamilyPsychotic DisordersAreaData SetPatternLaboratories
Grant awards (64)
Laboratory for Early Psychosis Research (LEAP)$1,969,525
P50 · FY2025 · MH · contact PI
Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)$922,729
P50 · FY2025 · MH · contact PI
Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology$762,422
R01 · FY2025 · MH
3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$373,589
R01 · FY2025 · MH · contact PI
LEAP Administrative Core$268,356
P50 · FY2025 · MH · contact PI
Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia$246,000
R21 · FY2025 · MH
Measuring brain lactate and other metabolites in schizophrenia at 3T using an enhanced MR spectroscopy approach$205,000
R21 · FY2025 · MH
Laboratory for Early Psychosis Research (LEAP)$2,037,513
P50 · FY2024 · MH · contact PI
Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)$990,361
P50 · FY2024 · MH · contact PI
Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology$844,822
R01 · FY2024 · MH
LEAP Administrative Core$428,360
P50 · FY2024 · MH · contact PI
3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST)$389,921
R01 · FY2024 · MH · contact PI
Measuring brain lactate and other metabolites in schizophrenia at 3T using an enhanced MR spectroscopy approach$246,000
R21 · FY2024 · MH
Laboratory for Early Psychosis Research (LEAP)$2,138,706
P50 · FY2023 · MH · contact PI
Randomized controlled trial of enhanced coordinated specialty care (CSC 2.0)$1,026,589
P50 · FY2023 · MH · contact PI
LEAP Administrative Core$483,836
P50 · FY2023 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$424,079
R01 · FY2023 · MH
American Psychopathological Association 2023 Annual Meeting$25,000
R13 · FY2023 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,634,573
P50 · FY2022 · MH · contact PI
LEAP Administrative Core$1,043,947
P50 · FY2022 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$496,117
R01 · FY2022 · MH
LEAP Administrative Core$100,000
P50 · FY2022 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$100,000
P50 · FY2022 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,640,084
P50 · FY2021 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$496,117
R01 · FY2021 · MH
LEAP Administrative Core$444,588
P50 · FY2021 · MH · contact PI
Enhancing the Data Science Capabilities$443,527
P50 · FY2021 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,704,908
P50 · FY2020 · MH · contact PI
LEAP Administrative Core$701,568
P50 · FY2020 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$514,703
R01 · FY2020 · MH
Enhancing the Data Science Capabilities$350,311
P50 · FY2020 · MH · contact PI
ConProject-004$44,797
P50 · FY2020 · MH · contact PI
ConProject-003$23,584
P50 · FY2020 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$1,467,963
P50 · FY2019 · MH · contact PI
Molecular Mechanisms and Biomarkers for Disease Progression from Prodrome to Early Psychosis$513,260
R01 · FY2019 · MH
LEAP Administrative Core$509,850
P50 · FY2019 · MH · contact PI
Enhancing the Data Science Capabilities$331,979
P50 · FY2019 · MH · contact PI
LEAP Administrative Core$320,161
P50 · FY2019 · MH · contact PI
Laboratory for Early Psychosis Research (LEAP)$320,161
P50 · FY2019 · MH · contact PI
Research and Mentoring on Brain and Peripheral Bioenergetics in Schizophrenia$157,733
K24 · FY2019 · MH · contact PI
Research and Mentoring on Brain and Peripheral Bioenergetics in Schizophrenia$157,733
K24 · FY2018 · MH · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$427,607
R01 · FY2017 · MH · contact PI
Research and Mentoring on Brain and Peripheral Bioenergetics in Schizophrenia$157,733
K24 · FY2017 · MH · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$968,613
R01 · FY2016 · MH · contact PI
Face processing systems in schizophrenia spectrum disorders$385,720
R01 · FY2016 · MH · contact PI
An MRI based in vivo measure of glutamatergic synaptic neurotransmission$316,000
R01 · FY2016 · MH · contact PI
Research and Mentoring on Brain and Peripheral Bioenergetics in Schizophrenia$157,733
K24 · FY2016 · MH · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$968,554
R01 · FY2015 · MH · contact PI
Probing the White Matter in Schizophrenia Using Novel MRS Techniques$355,500
R01 · FY2015 · MH · contact PI
An MRI based in vivo measure of glutamatergic synaptic neurotransmission$316,000
R01 · FY2015 · MH · contact PI
Research and Mentoring on Brain and Peripheral Bioenergetics in Schizophrenia$118,536
K24 · FY2015 · MH · contact PI
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients$657,215
R01 · FY2014 · MH · contact PI
Probing the White Matter in Schizophrenia Using Novel MRS Techniques$379,688
R01 · FY2014 · MH · contact PI
An MRI based in vivo measure of glutamatergic synaptic neurotransmission$316,000
R01 · FY2014 · MH · contact PI
Probing the White Matter in Schizophrenia Using Novel MRS Techniques$364,500
R01 · FY2013 · MH · contact PI
Genetics of Glutamatergic Neurotransmission$184,425
R21 · FY2013 · MH · contact PI
Probing the White Matter in Schizophrenia Using Novel MRS Techniques$340,188
R01 · FY2012 · MH · contact PI
Genetics of Glutamatergic Neurotransmission$231,326
R21 · FY2012 · MH · contact PI
Probing the White Matter in Schizophrenia Using Novel MRS Techniques$310,896
R01 · FY2011 · MH · contact PI
MRS Studies of Glutamate and GABA in Bipolar Dissorder$92,814
K23 · FY2011 · MH · contact PI
MRS Studies of Glutamate and GABA in Bipolar Dissorder$179,275
K23 · FY2010 · MH · contact PI
MRS Studies of Glutamate and GABA in Bipolar Dissorder$53,917
K23 · FY2010 · MH · contact PI
MRS Studies of Glutamate and GABA in Bipolar Dissorder$179,275
K23 · FY2009 · MH · contact PI
MRS Studies of Glutamate and GABA in Bipolar Dissorder$179,275
K23 · FY2008 · MH · contact PI